Controversy grows over parallel track for experimental AIDS drug.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000379:methods*; D016049:Didanosine / Q000627:therapeutic use*; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States
D016049:Didanosine